26 May 2013
Keywords: merck, serono, erbitux, nominated, prix, galien, german
Article | 20 October 2008
German drug major Merck Serono's Erbitux (cetuximab) is one of the finalists for the prestigious International Prix Galien Award for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 October 2008
24 May 2013
© 2013 thepharmaletter.com